Episode 136: Financial Hardship for Medical Professionals With Tyler Olson

Tyler Olson Headshot for a Podcast with Chadi Nabhan

Episode 136: Financial Hardship for Medical Professionals With Tyler Olson

Tyler Olson of Olson Consulting LLC joins the show to share his financial advice and planning for physicians and medical students as they go through their careers. Chadi and Tyler hit on the early financial decisions that medical students and early career physicians should make to support their lives as they deal with delayed income, why Tyler decided to open his own consulting firm, and why he focuses his consulting solely for the benefit of medical professionals. He shares how medical students and residents can see the trajectory of the debt they accumulate while in training and set a “plan to plan” and manage cash flow to alleviate that debt efficiently.

Related Resources

View resources on the Olson Consulting website: www.olsonconsultingmi.com/home

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 223: From Lab to Statup: Dr. Simrit Parmar on Launching Cellenkos

Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous

Read More

Episode 222: Language Matters: A Patient Perspective

Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those

Read More

Episode 221: Major Progress in Adjuvant Renal Cell Carcinoma

Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease

Read More